Descriptor
Source
| Science | 8 |
Author
| Bloom, David E. | 1 |
| Carliner, Geoffrey | 1 |
| Curran, James W. | 1 |
| Dickens, Bernard M. | 1 |
| Fauci, Anthony S. | 1 |
| Fineberg, Harvey V. | 1 |
| Piot, Peter | 1 |
| Price, Richard W. | 1 |
| Walters, LeRoy | 1 |
Publication Type
| Journal Articles | 8 |
| Reports - Descriptive | 8 |
| Opinion Papers | 2 |
| Numerical/Quantitative Data | 1 |
Education Level
Audience
| Policymakers | 8 |
| Practitioners | 8 |
| Researchers | 8 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewedBloom, David E.; Carliner, Geoffrey – Science, 1988
Claims that the lifetime cost of medicare per acquired immune deficiency syndrome (AIDS) patient will not exceed $80,000, an amount similar to the cost of treating other serious illnesses. Argues that the total projected costs for treating AIDS patients between 1981 and 1991 will not exceed $22 billion. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Cost Estimates, Costs, Disease Control
Peer reviewedDickens, Bernard M. – Science, 1988
Provides an overview of some major areas of legal concern in which the acquired immune deficiency syndrome (AIDS) epidemic is having an impact. Reviews rights of confidentiality and nondiscrimination regarding access to health care, employment, housing, education, and insurance. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Compliance (Legal), Discriminatory Legislation, Disease Control
Peer reviewedFineberg, Harvey V. – Science, 1988
Discusses a number of obstacles that limit effective education for reducing the incidence of acquired immune deficiency syndrome (AIDS) in the United States. Includes behaviors that must be changed, disagreement about the propriety of educational messages to prevent AIDS, and uncertainty as to some of the dual messages of reassurance being…
Descriptors: Acquired Immune Deficiency Syndrome, Controversial Issues (Course Content), Disease Control, Drug Education
Peer reviewedFauci, Anthony S. – Science, 1988
Discusses how the infection of the human immunodeficiency virus (HIV) results in a profound immunosuppression due predominantly to a selective depletion of helper/inducer T lymphocytes that express the receptor for the virus, as well as neuropsychiatric abnormalities in the brain. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Disease Control, Epidemiology, Health Education
Peer reviewedPiot, Peter; And Others – Science, 1988
Discusses some of the worldwide problems associated with the acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus type 1 (HIV-1). Calls for programs for the prevention and control of AIDS as an immediate priority in all countries. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Disease Control, Foreign Countries, Global Approach
Peer reviewedCurran, James W.; And Others – Science, 1988
Reports that by the end of 1987, nearly 50,000 cases of acquired immune deficiency syndrome (AIDS) had been reported in the United States since 1981, with 20,745 in 1987 alone. Discusses the disordinate proportion of cases involving black and Hispanic adults and children. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Blacks, Disease Control, Drug Abuse
Peer reviewedPrice, Richard W.; And Others – Science, 1988
Discusses the complicated infection of human immunodeficiency virus type 1 (HIV-1) in its late stages of the acquired immune deficiency syndrome (AIDS) dementia complex. Explains the syndrome's development of abnormalities in cognition, motor performance, and behavior. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Behavior Change, Cognitive Structures, Disease Control
Peer reviewedWalters, LeRoy – Science, 1988
Poses questions about how we can control the acquired immune deficiency syndrome (AIDS) epidemic and the harm that it causes without unjustly discriminating against particular social groups and without unnecessarily infringing on the freedom of individuals. (TW)
Descriptors: Acquired Immune Deficiency Syndrome, Civil Rights, Discriminatory Legislation, Disease Control
